Literature DB >> 21538122

Aberrant activation-induced cytidine deaminase expression is associated with mucosal intestinalization in the early stage of gastric cancer.

Ayako Goto1, Minako Hirahashi, Mikako Osada, Kazuhiko Nakamura, Takashi Yao, Masazumi Tsuneyoshi, Ryoichi Takayanagi, Yoshinao Oda.   

Abstract

Although Helicobacter pylori is a risk factor for gastric cancer (GC), its detailed carcinogenesis remains unclear. Recently, aberrant expression of activation-induced cytidine deaminase (AID) was demonstrated in gastric epithelium with H. pylori infection and seems to cause the accumulation of mutation. This investigation aims to elucidate whether or not AID expression plays an important role in the carcinogenesis of early GC. We examined the correlation between immunohistochemical AID expression and histological characteristics, including pre-existing chronic gastritis and cellular mucin phenotype in 138 cases of intramucosal GC. Furthermore, we investigated the relationship between AID, p53 protein, and β-catenin. The low degree of polymorphonuclear neutrophil activity, and the high degree of glandular atrophy and intestinal metaplasia were significantly correlated with the high levels of AID expression in non-neoplastic mucosa (P = 0.007, P ≤ 0.001, and P = 0.003). With regard to mucin phenotype of carcinoma, the intestinal phenotype tended to have the higher AID expression levels (P = 0.052). AID showed close correlations with Cdx2 and nuclear staining of β-catenin (P = 0.003, P = 0.034). As for p53 protein, no correlation was found with AID expression. Our findings suggest that aberrant AID expression is correlated with persistent inflammatory condition induced by H. pylori infection and may contribute to the development of GC through an inflammatory condition and intestinalization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538122     DOI: 10.1007/s00428-011-1086-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  34 in total

1.  CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.

Authors:  Hyung-Seok Kim; Ji-Shin Lee; Jean-Noel Freund; Kyung-Whan Min; Jeong-Soo Lee; Wan Kim; Sang-Woo Juhng; Chang-Soo Park
Journal:  J Gastroenterol Hepatol       Date:  2006-02       Impact factor: 4.029

2.  Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling.

Authors:  Y Endo; H Marusawa; K Kinoshita; T Morisawa; T Sakurai; I-M Okazaki; K Watashi; K Shimotohno; T Honjo; T Chiba
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

3.  Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome.

Authors:  H Grabsch; S Takeno; T Noguchi; G Hommel; H E Gabbert; W Mueller
Journal:  Histopathology       Date:  2001-08       Impact factor: 5.087

4.  Gastric or intestinal phenotypic expression in the carcinomas and background mucosa of multiple early gastric carcinomas.

Authors:  A Kabashima; T Yao; K Sugimachi; M Tsuneyoshi
Journal:  Histopathology       Date:  2000-12       Impact factor: 5.087

5.  CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene.

Authors:  Yun-Qing Bai; Satoshi Miyake; Takehisa Iwai; Yasuhito Yuasa
Journal:  Oncogene       Date:  2003-09-11       Impact factor: 9.867

6.  Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics.

Authors:  Shunji Kato; Norio Matsukura; Katsuya Tsukada; Noriko Matsuda; Tsutomu Mizoshita; Tetsuya Tsukamoto; Masae Tatematsu; Yuichi Sugisaki; Zenya Naito; Takashi Tajiri
Journal:  Cancer Sci       Date:  2007-06       Impact factor: 6.716

7.  Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression.

Authors:  Toshiyuki Morisawa; Hiroyuki Marusawa; Yoshihide Ueda; Akio Iwai; Il-mi Okazaki; Tasuku Honjo; Tsutomu Chiba
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

8.  Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer.

Authors:  K Maeda; S M Kang; N Onoda; M Ogawa; T Sawada; B Nakata; Y Kato; Y S Chung; M Sowa
Journal:  Oncology       Date:  1998 Nov-Dec       Impact factor: 2.935

9.  Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma.

Authors:  Junji Komori; Hiroyuki Marusawa; Takafumi Machimoto; Yoko Endo; Kazuo Kinoshita; Tadayuki Kou; Hironori Haga; Iwao Ikai; Shinji Uemoto; Tsutomu Chiba
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

10.  Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines.

Authors:  Patrícia Mesquita; Nicolas Jonckheere; Raquel Almeida; Marie-Paule Ducourouble; Jacinta Serpa; Elisabete Silva; Pascal Pigny; Filipe Santos Silva; Celso Reis; Debra Silberg; Isabelle Van Seuningen; Leonor David
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

View more
  9 in total

1.  Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.

Authors:  Rodolfo Villarreal-Calderon; Arturo Luévano-González; Mariana Aragón-Flores; Hongtu Zhu; Ying Yuan; Qun Xiang; Benjamin Yan; Kathryn Anne Stoll; Janet V Cross; Kenneth A Iczkowski; Alexander Craig Mackinnon
Journal:  Ann Diagn Pathol       Date:  2014-02-11       Impact factor: 2.090

2.  Expression of AID, P53, and Mlh1 proteins in endoscopically resected differentiated-type early gastric cancer.

Authors:  Yohei Takeda; Kazuo Yashima; Akihiro Hayashi; Shuji Sasaki; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki; Hisao Ito
Journal:  World J Gastrointest Oncol       Date:  2012-06-15

3.  AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa.

Authors:  Soichiro Kawata; Kazuo Yashima; Sohei Yamamoto; Shuji Sasaki; Yohei Takeda; Akihiro Hayashi; Kazuya Matsumoto; Koichiro Kawaguchi; Kenichi Harada; Yoshikazu Murawaki
Journal:  Oncol Lett       Date:  2015-06-09       Impact factor: 2.967

4.  Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication.

Authors:  Naoyoshi Nagata; Junichi Akiyama; Hiroyuki Marusawa; Takuro Shimbo; Yi Liu; Toru Igari; Ryo Nakashima; Hidenobu Watanabe; Naomi Uemura; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2013-04-18       Impact factor: 7.527

5.  Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma.

Authors:  Dessy Chan; Miriam Yuen-Tung Tsoi; Christina Di Liu; Sau-Hing Chan; Simon Ying-Kit Law; Kwok-Wah Chan; Yuen-Piu Chan; Vinod Gopalan; Alfred King-Yin Lam; Johnny Cheuk-On Tang
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

Review 6.  Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype.

Authors:  Naohide Oue; Kazuhiro Sentani; Naoya Sakamoto; Wataru Yasui
Journal:  Cancer Sci       Date:  2015-07-07       Impact factor: 6.716

7.  Aberrant expression of AID and AID activators of NF-κB and PAX5 is irrelevant to EBV-associated gastric cancers, but is associated with carcinogenesis in certain EBV-non-associated gastric cancers.

Authors:  Takashi Mohri; Keiko Nagata; Satoshi Kuwamoto; Michiko Matsushita; Hirotsugu Sugihara; Masako Kato; Yasushi Horie; Ichiro Murakami; Kazuhiko Hayashi
Journal:  Oncol Lett       Date:  2017-04-03       Impact factor: 2.967

8.  Activation-induced Cytidine Deaminase in B Cell Immunity and Cancers.

Authors:  Seok-Rae Park
Journal:  Immune Netw       Date:  2012-12-31       Impact factor: 6.303

9.  Role of activation-induced cytidine deaminase in the development of oral squamous cell carcinoma.

Authors:  Yosuke Nakanishi; Satoru Kondo; Naohiro Wakisaka; Akira Tsuji; Kazuhira Endo; Shigeyuki Murono; Makoto Ito; Kouichi Kitamura; Masamichi Muramatsu; Tomokazu Yoshizaki
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.